Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19
Clinical trial NCT04347239 · COMPLETED
Trial details
- NCT number
- NCT04347239
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2021-10-24
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.